Pharmacogenetics of schizophrenia: Bringing 'order to chaos' in the psychopharmacology of schizophrenia?

Peter F Buckley, Del D. Miller, Adriana Elena Foster

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

The inherent wide interindividual variability in response and tolerability of side effects in the treatment of schizophrenia itself provides a compelling rationale for the great potential of pharmacogenetics. Moreover, this potential is consonant with the broader public health directive toward personalized medicine. Within schizophrenia, the progress thus far has been modest in both the treatment response and adverse effect domains. This chapter chronicles the progress made in the quest for pharmacogenetic predictors in the treatment of schizophrenia.

Original languageEnglish (US)
Title of host publicationAdvances in Biological Psychiatry
EditorsMatthias Schwab, Matthias Schwab, Kaschka Wolfgang, Edoardo Spina
Pages46-57
Number of pages12
DOIs
StatePublished - Dec 1 2010

Publication series

NameAdvances in Biological Psychiatry
Volume25
ISSN (Print)0378-7354
ISSN (Electronic)1662-2774

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Buckley, P. F., Miller, D. D., & Foster, A. E. (2010). Pharmacogenetics of schizophrenia: Bringing 'order to chaos' in the psychopharmacology of schizophrenia? In M. Schwab, M. Schwab, K. Wolfgang, & E. Spina (Eds.), Advances in Biological Psychiatry (pp. 46-57). (Advances in Biological Psychiatry; Vol. 25). https://doi.org/10.1159/000317298